Consonance Capital Management as of March 31, 2019
Portfolio Holdings for Consonance Capital Management
Consonance Capital Management holds 26 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amarin Corporation (AMRN) | 14.4 | $228M | 11M | 20.76 | |
| United Therapeutics Corporation (UTHR) | 9.1 | $144M | 1.2M | 117.37 | |
| Pacira Pharmaceuticals (PCRX) | 8.8 | $139M | 3.7M | 38.06 | |
| Uniqure Nv (QURE) | 7.5 | $118M | 2.0M | 59.65 | |
| Myriad Genetics (MYGN) | 6.9 | $110M | 3.3M | 33.20 | |
| Retrophin | 5.8 | $91M | 4.0M | 22.63 | |
| Catalyst Pharmaceutical Partners (CPRX) | 5.8 | $91M | 18M | 5.10 | |
| Aerie Pharmaceuticals | 5.1 | $81M | 1.7M | 47.50 | |
| Vanda Pharmaceuticals (VNDA) | 5.0 | $78M | 4.3M | 18.40 | |
| Vericel (VCEL) | 4.7 | $75M | 4.3M | 17.51 | |
| Urogen Pharma (URGN) | 4.1 | $65M | 1.8M | 36.94 | |
| Oxford Immunotec Global | 2.8 | $45M | 2.6M | 17.23 | |
| Corcept Therapeutics Incorporated (CORT) | 2.8 | $44M | 3.7M | 11.74 | |
| Epizyme | 2.7 | $43M | 3.5M | 12.39 | |
| Omeros Corporation (OMER) | 2.3 | $37M | 2.1M | 17.37 | |
| Kadmon Hldgs | 1.9 | $31M | 12M | 2.64 | |
| Karyopharm Therapeutics (KPTI) | 1.9 | $30M | 5.2M | 5.84 | |
| Aurinia Pharmaceuticals (AUPH) | 1.7 | $27M | 4.2M | 6.50 | |
| Chemocentryx | 1.5 | $23M | 1.7M | 13.89 | |
| Savara (SVRA) | 1.4 | $23M | 3.1M | 7.37 | |
| Adma Biologics (ADMA) | 1.1 | $17M | 4.6M | 3.79 | |
| Akebia Therapeutics (AKBA) | 0.7 | $12M | 1.4M | 8.19 | |
| Iovance Biotherapeutics (IOVA) | 0.7 | $11M | 1.1M | 9.51 | |
| Biosante Pharmaceuticals (ANIP) | 0.6 | $10M | 143k | 70.54 | |
| Radius Health Inc note 3.000% 9/0 | 0.5 | $7.5M | 9.0M | 0.83 | |
| Immunomedics | 0.2 | $2.8M | 145k | 19.21 |
